{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:14:26Z","timestamp":1789377266658,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,11]],"date-time":"2012-03-11T00:00:00Z","timestamp":1331424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10585-012-9462-8","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T07:21:55Z","timestamp":1331364115000},"page":"441-456","source":"Crossref","is-referenced-by-count":36,"title":["Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions"],"prefix":"10.1007","volume":"29","author":[{"given":"Christina","family":"Reufsteck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Lifshitz-Shovali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gershon","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,11]]},"reference":[{"key":"9462_CR1","doi-asserted-by":"crossref","DOI":"10.1201\/9780203852569","volume-title":"The biology of cancer","author":"RA Weinberg","year":"2006","unstructured":"Weinberg RA (2006) The biology of cancer. Garland Science, Oxford"},{"issue":"2 Suppl 6","key":"9462_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0093-7754(01)90262-3","volume":"28","author":"JR Berenson","year":"2001","unstructured":"Berenson JR (2001) Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials. Semin Oncol 28(2 Suppl 6):25\u201334","journal-title":"Semin Oncol"},{"issue":"14","key":"9462_CR3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199810013391407","volume":"339","author":"GN Hortobagyi","year":"1998","unstructured":"Hortobagyi GN (1998) Treatment of breast cancer. New Engl J Med 339(14):974\u2013984","journal-title":"New Engl J Med"},{"issue":"20","key":"9462_CR4","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1158\/1078-0432.CCR-09-1917","volume":"15","author":"HL McArthur","year":"2009","unstructured":"McArthur HL, Hudis CA (2009) Trastuzumab: a picky partner? Clin Cancer Res 15(20):6311\u20136313","journal-title":"Clin Cancer Res"},{"issue":"11","key":"9462_CR5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Engl J Med 344(11):783\u2013792","journal-title":"New Engl J Med"},{"issue":"3","key":"9462_CR6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","volume":"17","author":"RL Theriault","year":"1999","unstructured":"Theriault RL, Lipton A, Hortobagyi GN et al (1999) Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol 17(3):846\u2013854","journal-title":"J Clin Oncol"},{"issue":"7249","key":"9462_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang XH, Nadal C et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005\u20131009","journal-title":"Nature"},{"issue":"6","key":"9462_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3(6):537\u2013549","journal-title":"Cancer Cell"},{"issue":"9","key":"9462_CR9","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1096\/fasebj.3.9.2663581","volume":"3","author":"D Heinegard","year":"1989","unstructured":"Heinegard D, Oldberg A (1989) Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 3(9):2042\u20132051","journal-title":"FASEB J"},{"issue":"20","key":"9462_CR10","doi-asserted-by":"crossref","first-page":"12723","DOI":"10.1016\/S0021-9258(17)44236-0","volume":"258","author":"LW Fisher","year":"1983","unstructured":"Fisher LW, Whitson SW, Avioli LV et al (1983) Matrix sialoprotein of developing bone. J Biol Chem 258(20):12723\u201312727","journal-title":"J Biol Chem"},{"issue":"2","key":"9462_CR11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","volume":"280","author":"LW Fisher","year":"2001","unstructured":"Fisher LW, Torchia DA, Fohr B et al (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280(2):460\u2013465","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20134","key":"9462_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/03008208909049997","volume":"21","author":"M Noda","year":"1989","unstructured":"Noda M, Rodan GA (1989) Type beta transforming growth factor regulates expression of genes encoding bone matrix proteins. Connect Tissue Res 21(1\u20134):71\u201375","journal-title":"Connect Tissue Res"},{"issue":"1","key":"9462_CR13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1432-1033.1995.0183i.x","volume":"230","author":"Y Ogata","year":"1995","unstructured":"Ogata Y, Yamauchi M, Kim RH et al (1995) Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem\/FEBS 230(1):183\u2013192","journal-title":"Eur J Biochem\/FEBS"},{"issue":"4","key":"9462_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10555-006-9032-0","volume":"25","author":"J Pratap","year":"2006","unstructured":"Pratap J, Lian JB, Javed A et al (2006) Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 25(4):589\u2013600","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"9462_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/excr.1999.4765","volume":"254","author":"TV Byzova","year":"2000","unstructured":"Byzova TV, Kim W, Midura RJ et al (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254(2):299\u2013308","journal-title":"Exp Cell Res"},{"issue":"31","key":"9462_CR16","doi-asserted-by":"crossref","first-page":"28593","DOI":"10.1074\/jbc.M303445200","volume":"278","author":"R Das","year":"2003","unstructured":"Das R, Mahabeleshwar GH, Kundu GC (2003) Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase\/Akt signaling pathways in breast cancer cells. J Biol Chem 278(31):28593\u201328606","journal-title":"J Biol Chem"},{"issue":"5","key":"9462_CR17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0955-0674(03)00109-1","volume":"15","author":"KA DeMali","year":"2003","unstructured":"DeMali KA, Wennerberg K, Burridge K (2003) Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol 15(5):572\u2013582","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"9462_CR18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jcb.22211","volume":"107","author":"JA Gordon","year":"2009","unstructured":"Gordon JA, Sodek J, Hunter GK et al (2009) Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells. J Cell Biochem 107(6):1118\u20131128","journal-title":"J Cell Biochem"},{"issue":"10","key":"9462_CR19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","volume":"5","author":"W Guo","year":"2004","unstructured":"Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5(10):816\u2013826","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"9462_CR20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/35060120","volume":"3","author":"WB Kiosses","year":"2001","unstructured":"Kiosses WB, Shattil SJ, Pampori N et al (2001) Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat Cell Biol 3(3):316\u2013320","journal-title":"Nat Cell Biol"},{"issue":"2","key":"9462_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","volume":"16","author":"H Rangaswami","year":"2006","unstructured":"Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16(2):79\u201387","journal-title":"Trends Cell Biol"},{"issue":"1","key":"9462_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/B:CLIN.0000017167.17065.61","volume":"21","author":"JA Sharp","year":"2004","unstructured":"Sharp JA, Waltham M, Williams ED et al (2004) Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis 21(1):19\u201329","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"9462_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrc2345","volume":"8","author":"A Bellahcene","year":"2008","unstructured":"Bellahcene A, Castronovo V, Ogbureke KU et al (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8(3):212\u2013226","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"9462_CR24","first-page":"4060","volume":"7","author":"NS Fedarko","year":"2001","unstructured":"Fedarko NS, Jain A, Karadag A et al (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7(12):4060\u20134066","journal-title":"Clin Cancer Res"},{"issue":"5","key":"9462_CR25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jbmr.5650110514","volume":"11","author":"A Bellahcene","year":"1996","unstructured":"Bellahcene A, Kroll M, Liebens F et al (1996) Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 11(5):665\u2013670","journal-title":"J Bone Miner Res"},{"issue":"4","key":"9462_CR26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<350::AID-IJC19>3.0.CO;2-9","volume":"69","author":"A Bellahcene","year":"1996","unstructured":"Bellahcene A, Menard S, Bufalino R et al (1996) Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer 69(4):350\u2013353","journal-title":"Int J Cancer"},{"issue":"11 Pt 1","key":"9462_CR27","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-05-2354","volume":"12","author":"VH Bramwell","year":"2006","unstructured":"Bramwell VH, Doig GS, Tuck AB et al (2006) Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin Cancer Res 12(11 Pt 1):3337\u20133343","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9462_CR28","first-page":"3914","volume":"5","author":"IJ Diel","year":"1999","unstructured":"Diel IJ, Solomayer EF, Seibel MJ et al (1999) Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 5(12):3914\u20133919","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9462_CR29","first-page":"3417","volume":"62","author":"PS Rudland","year":"2002","unstructured":"Rudland PS, Platt-Higgins A, El-Tanani M et al (2002) Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 62(12):3417\u20133427","journal-title":"Cancer Res"},{"issue":"1","key":"9462_CR30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156652410791065381","volume":"10","author":"LA Shevde","year":"2010","unstructured":"Shevde LA, Das S, Clark DW et al (2010) Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 10(1):71\u201381","journal-title":"Curr Mol Med"},{"issue":"3","key":"9462_CR31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ijc.23542","volume":"123","author":"BD Hedley","year":"2008","unstructured":"Hedley BD, Welch DR, Allan AL et al (2008) Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Int J Cancer 123(3):526\u2013534","journal-title":"Int J Cancer"},{"issue":"5","key":"9462_CR32","first-page":"1235","volume":"24","author":"H Adwan","year":"2004","unstructured":"Adwan H, Bauerle T, Najajreh Y et al (2004) Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. Int J Oncol 24(5):1235\u20131244","journal-title":"Int J Oncol"},{"issue":"2","key":"9462_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.cgt.7700659","volume":"11","author":"H Adwan","year":"2004","unstructured":"Adwan H, Bauerle TJ, Berger MR (2004) Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 11(2):109\u2013120","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"9462_CR34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0973-1482.82912","volume":"7","author":"M Uccello","year":"2011","unstructured":"Uccello M, Malaguarnera G, Vacante M et al (2011) Serum bone sialoprotein levels and bone metastases. J Cancer Res Ther 7(2):115\u2013119","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"9462_CR35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.20840","volume":"115","author":"T Bauerle","year":"2005","unstructured":"Bauerle T, Adwan H, Kiessling F et al (2005) Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer 115(2):177\u2013186","journal-title":"Int J Cancer"},{"issue":"2","key":"9462_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0005-2728(01)00198-0","volume":"1552","author":"GF Weber","year":"2001","unstructured":"Weber GF (2001) The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552(2):61\u201385","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"9462_CR37","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ijc.24890","volume":"126","author":"V Elazar","year":"2010","unstructured":"Elazar V, Adwan H, Bauerle T et al (2010) Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis. Int J Cancer 126(7):1749\u20131760","journal-title":"Int J Cancer"},{"issue":"5","key":"9462_CR38","first-page":"347","volume":"1","author":"N Dias","year":"2002","unstructured":"Dias N, Stein CA (2002) Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 1(5):347\u2013355","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"9462_CR39","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.gt.3301830","volume":"9","author":"H Cohen-Sacks","year":"2002","unstructured":"Cohen-Sacks H, Najajreh Y, Tchaikovski V et al (2002) Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther 9(23):1607\u20131616","journal-title":"Gene Ther"},{"issue":"6","key":"9462_CR40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/10717541003777225","volume":"17","author":"V Elazar","year":"2010","unstructured":"Elazar V, Adwan H, Rohekar K et al (2010) Biodistribution of antisense nanoparticles in mammary carcinoma rat model. Drug Deliv 17(6):408\u2013418","journal-title":"Drug Deliv"},{"issue":"1","key":"9462_CR41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2009.09.023","volume":"31","author":"JS Park","year":"2010","unstructured":"Park JS, Na K, Woo DG et al (2010) Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 31(1):124\u2013132","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"9462_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-4889(96)00067-5","volume":"1314","author":"DR Senger","year":"1996","unstructured":"Senger DR, Perruzzi CA (1996) Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim Biophys Acta 1314(1\u20132):13\u201324","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"9462_CR43","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/nar\/gkn190","volume":"36","author":"C Dahlgren","year":"2008","unstructured":"Dahlgren C, Zhang HY, Du Q et al (2008) Analysis of siRNA specificity on targets with double-nucleotide mismatches. Nucleic Acids Res 36(9):e53","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"9462_CR44","doi-asserted-by":"crossref","first-page":"e13558","DOI":"10.1371\/journal.pone.0013558","volume":"5","author":"J He","year":"2010","unstructured":"He J, Zhang JF, Yi C et al (2010) miRNA-mediated functional changes through co-regulating function related genes. PLoS ONE 5(10):e13558","journal-title":"PLoS ONE"},{"issue":"4","key":"9462_CR45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1023\/A:1016119328968","volume":"7","author":"C Soldani","year":"2002","unstructured":"Soldani C, Scovassi AI (2002) Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7(4):321\u2013328","journal-title":"Apoptosis"},{"issue":"15","key":"9462_CR46","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","volume":"13","author":"A Gross","year":"1999","unstructured":"Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13(15):1899\u20131911","journal-title":"Genes Dev"},{"issue":"4","key":"9462_CR47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/bcr65","volume":"2","author":"MJ Duffy","year":"2000","unstructured":"Duffy MJ, Maguire TM, Hill A et al (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2(4):252\u2013257","journal-title":"Breast Cancer Res"},{"issue":"3","key":"9462_CR48","first-page":"573","volume":"28","author":"T Bauerle","year":"2006","unstructured":"Bauerle T, Peterschmitt J, Hilbig H et al (2006) Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. Int J Oncol 28(3):573\u2013583","journal-title":"Int J Oncol"},{"issue":"6","key":"9462_CR49","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10585-007-9082-x","volume":"24","author":"J Peterschmitt","year":"2007","unstructured":"Peterschmitt J, Bauerle T, Berger MR (2007) Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231(GFP) breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude rats. Clin Exp Metastasis 24(6):449\u2013459","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"9462_CR50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1593\/neo.08220","volume":"10","author":"T Bauerle","year":"2008","unstructured":"Bauerle T, Hilbig H, Bartling S et al (2008) Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. Neoplasia 10(5):511\u2013520","journal-title":"Neoplasia"},{"issue":"2","key":"9462_CR51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10585-006-9013-2","volume":"23","author":"LA Shevde","year":"2006","unstructured":"Shevde LA, Samant RS, Paik JC et al (2006) Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis 23(2):123\u2013133","journal-title":"Clin Exp Metastasis"},{"issue":"7291","key":"9462_CR52","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","volume":"464","author":"ME Davis","year":"2010","unstructured":"Davis ME, Zuckerman JE, Choi CH et al (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291):1067\u20131070","journal-title":"Nature"},{"issue":"6","key":"9462_CR53","first-page":"503","volume":"12","author":"BB Lundberg","year":"1997","unstructured":"Lundberg BB (1997) Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture. Anticancer Drug Des 12(6):503\u2013513","journal-title":"Anticancer Drug Des"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-012-9462-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9462-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T08:34:35Z","timestamp":1713688475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-012-9462-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,11]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9462"],"URL":"https:\/\/doi.org\/10.1007\/s10585-012-9462-8","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,11]]}}}